gamma-carboline has been researched along with Alzheimer Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arndt, HD; Gaube, F; Raztsou, I; Robaa, D; Rohrbach, MM; Sager, H; Schätz, B; Schwarthoff, S; Tischer, N; Winckler, T | 1 |
| Bachurin, SO; Boltneva, NP; Kovaleva, NV; Lushchekina, SV; Makhaeva, GF; Richardson, RJ; Rudakova, EV; Shevtsova, EF | 1 |
| Appenroth, D; Enzensperger, C; Fleck, C; Gaube, F; Lehmann, J; Otto, R; Penzis, R; Tränkle, C; Winckler, T | 1 |
| Aksinenko, AY; Aliev, G; Bachurin, SO; Barreto, GE; Boltneva, NP; Grigoriev, VV; Lushchekina, SV; Makhaeva, GF; Serebryakova, OG; Sokolov, VB; Vikhareva, EA | 1 |
1 review(s) available for gamma-carboline and Alzheimer Disease
| Article | Year |
|---|---|
Overview of novel multifunctional agents based on conjugates of γ-carbolines, carbazoles, tetrahydrocarbazoles, phenothiazines, and aminoadamantanes for treatment of Alzheimer's disease.
Topics: Adamantane; Alzheimer Disease; Binding Sites; Carbazoles; Carbolines; Cholinesterase Inhibitors; Cholinesterases; Humans; Molecular Docking Simulation; Phenothiazines | 2019 |
3 other study(ies) available for gamma-carboline and Alzheimer Disease
| Article | Year |
|---|---|
Evaluation of γ-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Carbolines; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Phenothiazines; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2021 |
Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison.
Topics: Adjuvants, Anesthesia; Alzheimer Disease; Animals; Anti-Anxiety Agents; Carbolines; Cognition Disorders; Female; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Scopolamine; Structure-Activity Relationship | 2014 |
Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease.
Topics: Alzheimer Disease; Animals; Binding Sites; Butyrylcholinesterase; Carbolines; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Drug Design; Enzyme Activation; Humans; Models, Chemical; Molecular Docking Simulation; Phenothiazines; Protein Binding; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2015 |